| Oct 29 |
Perspective Therapeutics to Participate in Upcoming Investor Conferences in November
|
| Oct 24 |
UBS launches SMID cap biotechs with cancer, autoimmunity in focus
|
| Oct 23 |
Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine
|
| Oct 16 |
Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey
|
| Oct 12 |
Perspective Therapeutics, Inc (CATX): A Small-Cap Pioneer in Targeted Cancer Therapies
|
| Oct 11 |
Perspective falls after data for radiopharmaceutical in skin cancer
|
| Oct 11 |
Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research
|
| Oct 10 |
Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research
|
| Oct 7 |
Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day
|
| Oct 1 |
Perspective Therapeutics a new buy at Wedbush on radiopharmaceutical assets
|
